Bicara Therapeutics Inc. (BCAX) Deep Dive Video

Summary

Bicara is a well-funded, high-risk oncology bet whose upside hinges on whether ficerafusp alfa can convert promising early survival data into pivotal Phase 3 success.

View BCAX stock page · Read the BCAX research report

Loading the video player…